Ever Source Wealth Advisors, LLC Myriad Genetics Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 481 shares of MYGN stock, worth $6,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
481
Previous 481
-0.0%
Holding current value
$6,575
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MYGN
# of Institutions
252Shares Held
90.5MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$141 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$91.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$70.8 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$64.3 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.1B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...